Regional expansion KFSH&RC is expanding facilities within Riyadh and has ongoing plans to establish a dedicated manufacturing facility for genetic and cellular therapies on the Riyadh campus, signaling opportunities for equipment, facility management, and biomanufacturing partnerships.

Research and trials With a centralized Clinical Trials service launched in 2020 and active participation in clinical and research studies, there is potential for partnerships in trial management software, data analytics, patient recruitment services, and CRO collaborations.

Top-tier recognition Multiple accreditations and rankings (JCI, Magnet status, Stage 7 HIMSS EMR) and recent Health Performance Award honors demonstrate a mature, quality-focused buyer profile for enterprise IT, quality improvement, patient experience solutions, and hospital operations software.

Strategic specialties Leader in Oncology, Organ Transplantation, Cardiovascular Diseases, Neurosciences, and Genetic Diseases positions the hospital for advanced medical devices, imaging, genomic services, and specialized supply chain partnerships tailored to high-complexity care.

Global footprint As a major tertiary/quaternary center with 16,000+ employees across multiple Saudi locations and a strong branding position in the Middle East and Africa, there is opportunity for vendor relationships in workforce solutions, training programs, telemedicine platforms, and international collaboration initiatives.